FAQ/Help |
Calendar |
Search |
Today's Posts |
|
![]() |
#1 | |||
|
||||
Junior Member
|
I do have to agree.
I keep forgetting that Pharms are not "Not For Profit" companies. They are entitled to make a profit. I guess it's a matter of opinioun of how much is too much.
__________________
Occam's Razor . |
|||
![]() |
![]() |
![]() |
#2 | |||
|
||||
Member
|
The NMSS has invested $1 million in Apitope for their research. If it is successful they will share in the profits. The CRAB medications are more than $25,000 per year. oral laquinimod has been accepted by the FDA for fast track. It is looking better and better for the future.
__________________
Bill SCUBA, the true meaning of Life San Francisco Maru 2009 USS Monitor 1996, 1997, 1999 Andrea Doria 1996, 1998 USS Wilkes Barre 1991 |
|||
![]() |
![]() |
Reply |
Thread Tools | |
Display Modes | |
|
|
![]() |
||||
Thread | Forum | |||
Pipeline Insight: Orphan Diseases in CNS - Part II: Amyotrophic Lateral Sclerosis | ALS News & Research | |||
Parkinson Pipeline Project...survery results | Parkinson's Disease | |||
Parkinson Pipeline Database | Parkinson's Disease | |||
Als Clinical Trials: State Of The Pipeline | ALS | |||
Safinamide in the Pipeline: triple action | Parkinson's Disease |